Pro Health Fitness


URGENT: Heart Devices for Blockage Issues Linked to 273 Injuries and 14 Deaths in the US!

Heart Devices for Blockage Issues

United States: Two implanted heart devices for end-stage heart failure are now subject to a strict US Food and Drug Administration (FDA) recall after 273 injuries and 14 deaths were found to be linked to it, as told by the agency on Tuesday.

HeartMate II and HeartMate 3 were created by Thoratec Corp., which is an affiliate or subsidiary of Abbott Laboratories. About 14,000 out of these most likely are the devices being subject to the contamination, but the devices are not yet being recalled from the market.

The FDA stated, “The HeartMate II and 3 are used for both short- and long-term support in adult patients with severe left ventricular heart failure,” as the US News reported.

Moreover, “It can be used while waiting for a heart transplant, to help the heart recover, or as a permanent solution when a transplant isn’t an option,” said the agency.

More about the devices

The devices become a substitute of the heart’s main pumping chamber’s action. The new ‘left ventricle’ is the left ventricular assist device. They really take the blood from the stimulated chamber and force it into the aorta, then circulating it further into the body.

Furthermore, in exceptional instances, the tubes sometimes cascade “biological material” supporting it somewhere along the lines.

FDA added, “This buildup can obstruct the device, making it less effective in helping the heart pump blood,” and, “It can trigger alarms indicating low blood flow and affect the device’s ability to help the heart properly. The accumulation of biological material typically occurs over two years or more.”

Moreover, as per the agency, such kind of obstruction also caused lethal injuries or even death in worst-case scenarios.

Steps by officials to medical aid the affected

As per the FDA statement published on February 19, “sent all affected customers an Urgent Medical Device Correction Letter,” and further seeking to focus on alarms related to the devices, “as this is the first symptom of significant outflow obstruction,” as US News reported.

Moreover, If such alarms are being told to the doctors, they can in return either look into the matter by closely examine the patients internal readings, and also by implanting stent to manage the blood flow or replacing the pump.

The findings of the study were published in the Journal of Thoracic and Cardiovascular Surgery on 2022. The researchers found that the hindrances in blood flow occur in almost 3 percent of patients carrying the device, where there is chances of increasing risk of receiving obsrruction with time.

Dr. Francis Pagani, who is a cardiothoracic surgeon at the University of Michigan, said in case such devices are not present, then “we are in trouble,” however. “It would be devastating to the patients to not have this option. It’s not a perfect option — no pump ever is — but this is as good as it’s ever been,” as US News reported.

Leave a Reply

Your email address will not be published. Required fields are marked *